New Key Statistics Module, Z-Score and F-Score
OTCPK:BLSIF Key Ratios
| Market Cap $ M | 8.29 |
| Enterprise Value $ M | -3.88 |
| P/E(ttm) | 0.64 |
| PE Ratio without NRI | 5.83 |
| Forward PE Ratio | -- |
| Price/Book | 0.55 |
| Price/Sales | 35.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 0.93 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.08 |
| Beneish M-Score | 0.75 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.40 |
| EV-to-EBITDA | -0.39 |
| PEG | -- |
| Shares Outstanding M | 164.59 |
| Net Margin (%) | 3,084.42 |
| Operating Margin % | -298.74 |
| Pre-tax Margin (%) | 2,859.37 |
| Quick Ratio | 6.57 |
| Current Ratio | 6.57 |
| ROA % (ttm) | 94.32 |
| ROE % (ttm) | 133.48 |
| ROIC % (ttm) | -31.35 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.00 |
BLSIF Number of Guru Trades
BLSIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BLSIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BLSIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Britannia Life Sciences Inc Insider Transactions
No Available Data
News about OTCPK:BLSIF
Total 0- 1